The US Food and Drug Administration has approved the powerful wakefulness-promoting medication Modafresh 200 USA to treat excessive daytime sleepiness in people with narcolepsy, shift work disorder, and obstructive sleep apnea/hypopnea syndrome. It is a CNS stimulant that functions as a reuptake inhibitor of the dopamine transporter (DAT), and its wakefulness-promoting effects are caused by an increase in brain dopamine levels. Additionally, Modafinil causes the hypothalamus's orexin neurons to release a range of peptides that both promote awake and prevent sleep.
Best Online Pharmacy In USA: Buysafepills
Our Mission... “To assist disaster survivors by providing a source for them to come together in time of need, to aid in the listing of events, information and other forms of assistance, and continuing support through the recovery process.”
Share this page with your family and friends.